Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial von Musa, Ahmed M, Mbui, Jane, Mohammed, Rezika, Olobo, Joseph, Ritmeijer, Koert, Alcoba, Gabriel, Muthoni Ouattara, Gina, Egondi, Thaddaeus, Nakanwagi, Prossy, Omollo, Truphosa, Wasunna, Monique, Verrest, Luka, Dorlo, Thomas P C, Musa Younis, Brima, Nour, Ali, Taha Ahmed Elmukashfi, Elmukashfi, Ismail Omer Haroun, Ahmed, Khalil, Eltahir A G, Njenga, Simon, Fikre, Helina, Mekonnen, Tigist, Mersha, Dagnew, Sisay, Kasaye, Sagaki, Patrick, Alvar, Jorge, Solomos, Alexandra, Alves, Fabiana

Volltext

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial von Khalil, Eltahir A G, Weldegebreal, Teklu, Younis, Brima M, Omollo, Raymond, Musa, Ahmed M, Hailu, Workagegnehu, Abuzaid, Abuzaid A, Dorlo, Thomas P C, Hurissa, Zewdu, Yifru, Sisay, Haleke, William, Smith, Peter G, Ellis, Sally, Balasegaram, Manica, EL-Hassan, Ahmed M, Schoone, Gerard J, Wasunna, Monique, Kimutai, Robert, Edwards, Tansy, Hailu, Asrat

Volltext

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa von Chu, Wan-Yu, Verrest, Luka, Younis, Brima M, Musa, Ahmed M, Mbui, Jane, Mohammed, Rezika, Olobo, Joseph, Ritmeijer, Koert, Monnerat, Séverine, Wasunna, Monique, Roseboom, Ignace C, Solomos, Alexandra, Huitema, Alwin D R, Alves, Fabiana, Dorlo, Thomas P C

Volltext

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan von Younis, Brima M., Osman, Mohamed, Khalil, Eltahir A.G., Santoro, Francesco, Furini, Simone, Wiggins, Rebecca, Keding, Ada, Carraro, Monica, Musa, Anas E.A., Abdarahaman, Mujahid A.A., Mandefield, Laura, Bland, Martin, Aebischer, Toni, Gabe, Rhian, Layton, Alison M., Lacey, Charles J.N., Kaye, Paul M., Musa, Ahmed M.

Volltext

Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomy... von Roseboom, Ignace C., Thijssen, Bas, Rosing, Hilde, Alves, Fabiana, Younis, Brima M., Musa, Ahmed M., Beijnen, Jos H., Dorlo, Thomas P.C.

Volltext

Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa von Verrest, Luka, Kip, Anke E, Musa, Ahmed M, Schoone, Gerard J, Schallig, Henk D F H, Mbui, Jane, Khalil, Eltahir A G, Younis, Brima M, Olobo, Joseph, Were, Lilian, Kimutai, Robert, Monnerat, Séverine, Cruz, Isra, Wasunna, Monique, Alves, Fabiana, Dorlo, Thomas P C

Volltext

Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients von Verrest, Luka, Wasunna, Monique, Kokwaro, Gilbert, Aman, Rashid, Musa, Ahmed M., Khalil, Eltahir A. G., Mudawi, Mahmoud, Younis, Brima M., Hailu, Asrat, Hurissa, Zewdu, Hailu, Workagegnehu, Tesfaye, Samson, Makonnen, Eyasu, Mekonnen, Yalemtsehay, Huitema, Alwin D. R., Beijnen, Jos H., Kshirsagar, Smita A., Chakravarty, Jaya, Rai, Madhukar, Sundar, Shyam, Alves, Fabiana, Dorlo, Thomas P. C.

Volltext

Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study von Dorlo, Thomas P C, Kip, Anke E, Younis, Brima M, Ellis, Sally J, Alves, Fabiana, Beijnen, Jos H, Njenga, Simon, Kirigi, George, Hailu, Asrat, Olobo, Joseph, Musa, Ahmed M, Balasegaram, Manica, Wasunna, Monique, Karlsson, Mats O, Khalil, Eltahir A G

Volltext

A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis von Younis, Brima M., Wiggins, Rebecca, Khalil, Eltahir A.G., Osman, Mohamed, Santoro, Francesco, Sonnati, Chiara, Keding, Ada, Novedrati, Maria, Montesi, Giorgio, Noureldein, Ali, Elmukashfi, Elmukashfi T.A., Mustafa, Ala Eldin, Alamin, Mohammed, Saeed, Mohammed, Salman, Khalid, Suliman, Ahmed J., Musa, Amin E.A., Layton, Alison M., Lacey, Charles J.N., Kaye, Paul M., Musa, Ahmed M.

Volltext

Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Afri... von Omollo, Raymond, Alexander, Neal, Edwards, Tansy, Khalil, Eltahir A G, Younis, Brima M, Abuzaid, Abuzaid A, Wasunna, Monique, Njoroge, Njenga, Kinoti, Dedan, Kirigi, George, Dorlo, Thomas P C, Ellis, Sally, Balasegaram, Manica, Musa, Ahmed M

Volltext

The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs von Meheus, Filip, Abuzaid, Abuzaid A, Baltussen, Rob, Younis, Brima M, Balasegaram, Manica, Khalil, Eltahir A G, Boelaert, Marleen, Musa, Ahmed M

Volltext

Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study von Musa, Ahmed M, Younis, Brima, Fadlalla, Ahmed, Royce, Catherine, Balasegaram, Manica, Wasunna, Monique, Hailu, Asrat, Edwards, Tansy, Omollo, Raymond, Mudawi, Mahmoud, Kokwaro, Gilbert, El-Hassan, Ahmed, Khalil, Eltahir

Volltext

Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, rand... von Younis, Brima Musa, Mudawi Musa, Ahmed, Monnerat, Séverine, Abdelrahim Saeed, Mohammed, Awad Gasim Khalil, Eltahir, Elbashir Ahmed, Anas, Ahmed Ali, Mujahid, Noureldin, Ali, Muthoni Ouattara, Gina, Nyakaya, Godfrey M, Teshome, Samuel, Omollo, Truphosa, Ochieng, Michael, Egondi, Thaddaeus, Mmbone, Mildred, Chu, Wan-Yu, Dorlo, Thomas P C, Zijlstra, Eduard E, Wasunna, Monique, Alvar, Jorge, Alves, Fabiana

Volltext

LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasis von Lacey, Charles, Musa, Ahmed, Khalil, El Tahir, Younis, Brima, Osman, Mohamed, Wiggins, Rebecca, Keding, Ada, Kaye, Paul

Volltext

Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients von Salih, Mohamed A M, Fakiola, Michaela, Abdelraheem, Mohamed H, Younis, Brima M, Musa, Ahmed M, ElHassan, Ahmed M, Blackwell, Jenefer M, Ibrahim, Muntaser E, Mohamed, Hiba S

Volltext

Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome von Torres, Ana, Younis, Brima Musa, Alamin, Mohammed, Tesema, Samuel, Bernardo, Lorena, Solana, Jose Carlos, Moreno, Javier, Mustafa, Alaa-aldeen, Alves, Fabiana, Musa, Ahmed Mudawi, Carrillo, Eugenia

Volltext

Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines von Elfaki, Mona E.E., Khalil, Eltahir A.G., De Groot, Anne S., Musa, Ahmed M., Gutierrez, Andres, Younis, Brima M., Salih, Kawthar A.M., El-Hassan, Ahmed M.

Volltext

Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment von A, Abubakr O, M, Mohamed M, A, Hatim A, Elamin, Mohamed Y, Younis, Brima M, E, Mona E, Musa, Ahmed M, Elhassan, Ahmed M, G, Eltahir A

Volltext

Leishmania donovani-Induced Immune Dysregulation among Sudanese Patients with Visceral and Post Kala-Azar Dermal Leishmaniases: Possible Roles in Pathogenesis von Elsammani, E.E.M., Musa, Brima Younis, Elfaki, Mona Elfaki Eltahir, Mudawi, Ahmed Mudawi, Khalil, Eltahir Awad Gasim

Volltext

Immune-pathological phases of chronic Hepatitis B infections among Sudanese individuals towards personalization of management von Mohamed Mustafa Abbas, Shahd, Saeed Eltahir Saeed, Walla, Mohamed Musa, Osama, Elsamani Ahmed, Mugtaba, Mohamed H Satti, Maria, Musa Younis, Brima, Mudawi Musa, Ahmed, Gasim Khalil, Eltahir Awad

Volltext